Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Delays in Coccidioidomycosis Diagnosis and Associated Healthcare Utilization, Tucson, Arizona, USA.

Donovan FM, Wightman P, Zong Y, Gabe L, Majeed A, Ynosencio T, Bedrick EJ, Galgiani JN.

Emerg Infect Dis. 2019 Sep;25(9):1745-1747. doi: 10.3201/eid2509.190023.

PMID:
31441755
2.

Delays in Coccidioidomycosis Diagnosis and Relationship to Healthcare Utilization, Phoenix, Arizona, USA1.

Ginn R, Mohty R, Bollmann K, Goodsell J, Mendez G, Bradley B, Galgiani JN.

Emerg Infect Dis. 2019 Aug;25(9):1742-1744. doi: 10.3201/eid2509.190019. Epub 2019 Sep 17.

PMID:
31228403
3.

Coccidioidal Meningitis in New York traced to Texas by Fungal Genomic Analysis.

Barker BM, Rajan S, Teixeira MM, Sewnarine M, Roe C, Engelthaler DM, Galgiani JN.

Clin Infect Dis. 2019 Feb 1. doi: 10.1093/cid/ciz052. [Epub ahead of print]

PMID:
30715178
4.

Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.

Hung CY, Zhang H, Castro-Lopez N, Ostroff GR, Khoshlenar P, Abraham A, Cole GT, Negron A, Forsthuber T, Peng T, Galgiani JN, Ampel NM, Yu JJ.

Infect Immun. 2018 Oct 25;86(11). pii: e00070-18. doi: 10.1128/IAI.00070-18. Print 2018 Nov.

5.

Characterizing in vitro spherule morphogenesis of multiple strains of both species of Coccidioides.

Mead HL, Teixeira MM, Galgiani JN, Barker BM.

Med Mycol. 2019 Jun 1;57(4):478-488. doi: 10.1093/mmy/myy049.

PMID:
30053114
6.

Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Shubitz LF, Powell DA, Trinh HT, Lewis ML, Orbach MJ, Frelinger JA, Galgiani JN.

Vaccine. 2018 May 31;36(23):3375-3380. doi: 10.1016/j.vaccine.2018.04.026. Epub 2018 Apr 30.

7.

Top Questions in the Diagnosis and Treatment of Coccidioidomycosis.

Donovan FM, Zangeneh TT, Malo J, Galgiani JN.

Open Forum Infect Dis. 2017 Sep 12;4(4):ofx197. doi: 10.1093/ofid/ofx197. eCollection 2017 Fall.

8.

Oxygen Consumption Deficits in Patients With Residual Fatigue After Primary Coccidioidomycosis.

Ganley KJ, Bosch PR, Blair JE, Rischard F, Galgiani JN.

Open Forum Infect Dis. 2017 Jun 26;4(3):ofx136. doi: 10.1093/ofid/ofx136. eCollection 2017 Summer.

9.

Risk Factors for Disseminated Coccidioidomycosis, United States.

Odio CD, Marciano BE, Galgiani JN, Holland SM.

Emerg Infect Dis. 2017 Feb;23(2). doi: 10.3201/eid2302.160505.

10.

Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States.

Noble JA, Nelson RG, Fufaa GD, Kang P, Shafir SC, Galgiani JN.

Emerg Infect Dis. 2016 Oct;22(10):1821-3. doi: 10.3201/eid2210.160696.

11.

Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):717-22. doi: 10.1093/cid/ciw538.

PMID:
27559032
12.

A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.

Narra HP, Shubitz LF, Mandel MA, Trinh HT, Griffin K, Buntzman AS, Frelinger JA, Galgiani JN, Orbach MJ.

Infect Immun. 2016 Sep 19;84(10):3007-16. doi: 10.1128/IAI.00633-16. Print 2016 Oct.

13.

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):e112-46. doi: 10.1093/cid/ciw360. Epub 2016 Jul 27.

PMID:
27470238
14.

Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.

Shubitz LF, Trinh HT, Galgiani JN, Lewis ML, Fothergill AW, Wiederhold NP, Barker BM, Lewis ER, Doyle AL, Hoekstra WJ, Schotzinger RJ, Garvey EP.

Antimicrob Agents Chemother. 2015 Dec;59(12):7249-54. doi: 10.1128/AAC.00593-15. Epub 2015 Sep 14.

15.

A paradigm for the evaluation and management of spinal coccidioidomycosis.

Martirosyan NL, Skoch JM, Zaninovich O, Zoccali C, Galgiani JN, Baaj AA.

Surg Neurol Int. 2015 Jun 17;6:107. doi: 10.4103/2152-7806.158979. eCollection 2015. Review.

16.

The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis.

Wack EE, Ampel NM, Sunenshine RH, Galgiani JN.

Clin Infect Dis. 2015 Sep 1;61(5):787-91. doi: 10.1093/cid/civ388. Epub 2015 May 15. Review.

PMID:
25979308
17.

Application of immunosignatures for diagnosis of valley fever.

Navalkar KA, Johnston SA, Woodbury N, Galgiani JN, Magee DM, Chicacz Z, Stafford P.

Clin Vaccine Immunol. 2014 Aug;21(8):1169-77. doi: 10.1128/CVI.00228-14. Epub 2014 Jun 25.

18.

Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Shubitz LF, Trinh HT, Perrill RH, Thompson CM, Hanan NJ, Galgiani JN, Nix DE.

J Infect Dis. 2014 Jun 15;209(12):1949-54. doi: 10.1093/infdis/jiu029. Epub 2014 Jan 12.

19.

Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN.

Clin Microbiol Rev. 2013 Jul;26(3):505-25. doi: 10.1128/CMR.00005-13. Review.

20.

Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, Vinh DC, Browne SK, Datta S, Milner JD, Kuhns DB, Long Priel DA, Sadat MA, Shiloh M, De Marco B, Alvares M, Gillman JW, Ramarathnam V, de la Morena M, Bezrodnik L, Moreira I, Uzel G, Johnson D, Spalding C, Zerbe CS, Wiley H, Greenberg DE, Hoover SE, Rosenzweig SD, Galgiani JN, Holland SM.

J Allergy Clin Immunol. 2013 Jun;131(6):1624-34. doi: 10.1016/j.jaci.2013.01.052. Epub 2013 Mar 28.

Supplemental Content

Loading ...
Support Center